Brief: Medexus Announces Expanded Availability Of Trecondyv In Canada
Sept 21 (Reuters) - Medexus Pharmaceuticals Inc MDP.TO :
* MEDEXUS ANNOUNCES EXPANDED AVAILABILITY OF TRECONDYV®
(TREOSULFAN) IN CANADA
* MEDEXUS PHARMACEUTICALS INC - HAS INITIATED ITS FIRST
COMMERCIAL
SHIPMENT OF TRECONDYV® (TREOSULFAN) IN CANADA
Source text for Eikon: ID:nGNXbn5zWs
Further company coverage: MDP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million